Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oragenics Inc (OGEN)

Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oragenics Inc 9015 TOWN CENTER PARKWAY SUITE 143 LAKEWOOD RANCH FL 34202 USA

www.oragenics.com Employees: 6 P: 813-286-7900

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.

Key Statistics

Overview:

Market Capitalization, $K 2,385
Enterprise Value, $K -2,015
Shares Outstanding, K 4,336
Float, K 4,124
% Float 95.10%
Short Interest, K 793
Short Float 18.27%
Days to Cover 1.79
Short Volume Ratio 0.18
% of Insider Shareholders 4.90%
% of Institutional Shareholders 18.71%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -9,840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,290 K
EBIT, $ -9,360 K
EBITDA, $ -8,590 K

Growth:

1-Year Return -90.38%
3-Year Return -99.43%
5-Year Return -99.96%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.46%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.96 on 11/07/25
Next Earnings Date 05/08/26
Earnings Per Share ttm -8.66
EPS Growth vs. Prev Qtr 36.77%
EPS Growth vs. Prev Year 82.82%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 06/03/25

OGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -244.19%
Return-on-Assets % -136.78%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.29
Book Value/Share 1.94
Interest Coverage -11.63
60-Month Beta 1.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.